AngioMark: Phase II

In a 17-patient study, EPIX and partner Mallinckrodt Inc.'s AngioMark improved signal to noise ratios in some arterial segments at 0.05 mmol/kg. However, the compound did not improve SNR at 0.1 mmol/kg. Although specificity was considered good, sensitivity was not sufficient for clinical use, university researchers said. ...